WO2003022871A3 - Nouveaux inhibiteurs de dipeptidylpeptidase i - Google Patents
Nouveaux inhibiteurs de dipeptidylpeptidase i Download PDFInfo
- Publication number
- WO2003022871A3 WO2003022871A3 PCT/EP2002/010020 EP0210020W WO03022871A3 WO 2003022871 A3 WO2003022871 A3 WO 2003022871A3 EP 0210020 W EP0210020 W EP 0210020W WO 03022871 A3 WO03022871 A3 WO 03022871A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- unbranched
- branched
- chain
- heteroaryl
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02779316A EP1423410A2 (fr) | 2001-09-06 | 2002-09-06 | Inhibiteurs de dipeptidylpeptidase i renfermant un group hydroxylamino c-terminal |
JP2003526944A JP2005511505A (ja) | 2001-09-06 | 2002-09-06 | ジペプチジルペプチダーゼiの新規な阻害剤 |
AU2002342657A AU2002342657A1 (en) | 2001-09-06 | 2002-09-06 | Peptides having a c- terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10143840.0 | 2001-09-06 | ||
DE10143840A DE10143840A1 (de) | 2001-09-06 | 2001-09-06 | Neue Inhibitoren der Dipeptidylpeptidase I |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003022871A2 WO2003022871A2 (fr) | 2003-03-20 |
WO2003022871A3 true WO2003022871A3 (fr) | 2003-11-13 |
Family
ID=7698010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/010020 WO2003022871A2 (fr) | 2001-09-06 | 2002-09-06 | Nouveaux inhibiteurs de dipeptidylpeptidase i |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1423410A2 (fr) |
JP (1) | JP2005511505A (fr) |
AU (1) | AU2002342657A1 (fr) |
DE (1) | DE10143840A1 (fr) |
WO (1) | WO2003022871A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8883714B2 (en) | 2008-04-07 | 2014-11-11 | Arena Pharmaceuticals, Inc. | Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagogues |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040242566A1 (en) | 2003-03-25 | 2004-12-02 | Syrrx, Inc. | Dipeptidyl peptidase inhibitors |
ATE399763T1 (de) | 2003-05-30 | 2008-07-15 | Prozymex As | Proteasehemmer |
CN1867560A (zh) | 2003-08-13 | 2006-11-22 | 武田药品工株式会社 | 4-嘧啶酮衍生物及其作为肽基肽酶抑制剂的用途 |
US7169926B1 (en) | 2003-08-13 | 2007-01-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7678909B1 (en) | 2003-08-13 | 2010-03-16 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
EP1699777B1 (fr) | 2003-09-08 | 2012-12-12 | Takeda Pharmaceutical Company Limited | Inhibiteurs de la dipeptidylpeptidase |
US7732446B1 (en) | 2004-03-11 | 2010-06-08 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
CN102127053A (zh) | 2004-03-15 | 2011-07-20 | 武田药品工业株式会社 | 二肽基肽酶抑制剂 |
US20070286854A1 (en) * | 2004-04-28 | 2007-12-13 | Bayer Healthcare Ag | Diagnostics And Therapeutics For Diseases Associated With Dipeptidyl-Peptidase 1 (Dpp1) |
US7687638B2 (en) | 2004-06-04 | 2010-03-30 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
WO2006019965A2 (fr) | 2004-07-16 | 2006-02-23 | Takeda San Diego, Inc. | Inhibiteurs de la dipeptidyl peptidase |
EP2805953B1 (fr) | 2004-12-21 | 2016-03-09 | Takeda Pharmaceutical Company Limited | Inhibiteurs de peptidase dipeptidyl |
DOP2006000008A (es) | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
ME02005B (fr) | 2005-09-14 | 2012-08-31 | Takeda Pharmaceuticals Co | Inhibiteurs de la dipeptidyl peptidase permettant de traiter le diabete |
CA2622642C (fr) | 2005-09-16 | 2013-12-31 | Takeda Pharmaceutical Company Limited | Inhibiteurs de dipeptidylpeptidase |
PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
ES2354390T3 (es) | 2006-04-11 | 2011-03-14 | Arena Pharmaceuticals, Inc. | Procedimientos de uso del receptor gpr119 para identificar compuestos útiles para aumentar la masa ósea en un individuo. |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
AR077642A1 (es) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo |
CN102918027A (zh) | 2010-04-06 | 2013-02-06 | 艾尼纳制药公司 | Gpr119受体调节剂和对与所述受体有关的障碍的治疗 |
AU2011305525B2 (en) | 2010-09-22 | 2016-08-18 | Arena Pharmaceuticals, Inc. | Modulators of the GPR119 receptor and the treatment of disorders related thereto |
US20140018371A1 (en) | 2011-04-01 | 2014-01-16 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
WO2012145361A1 (fr) | 2011-04-19 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci |
US20140038889A1 (en) | 2011-04-22 | 2014-02-06 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
US20140051714A1 (en) | 2011-04-22 | 2014-02-20 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
WO2012170702A1 (fr) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulateurs du récepteur gpr119 et traitement de troubles associés à celui-ci |
WO2013055910A1 (fr) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulateurs du récepteur gpr119 et traitement de troubles associés |
WO2014074668A1 (fr) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulateurs de gpr119 et traitement de troubles associés à ceux-ci |
GB201415598D0 (en) | 2014-09-03 | 2014-10-15 | Univ Birmingham | Elavated Itercranial Pressure Treatment |
JP2018507914A (ja) | 2015-03-09 | 2018-03-22 | インテクリン・セラピューティクス・インコーポレイテッド | 非アルコール性脂肪肝疾患および/またはリポジストロフィーの処置のための方法 |
JP2020515639A (ja) | 2017-04-03 | 2020-05-28 | コヒラス・バイオサイエンシズ・インコーポレイテッド | 進行性核上性麻痺の処置のためのPPARγアゴニスト |
CN113292465B (zh) * | 2021-06-17 | 2022-11-08 | 贵州医科大学 | 一种半胱氨酸衍生物及其合成方法、应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998022494A2 (fr) * | 1996-11-22 | 1998-05-28 | Elan Pharmaceuticals, Inc. | METHODES ET COMPOSES DESTINES A INHIBER LA LIBERATION ET/OU LA SYNTHESE DU PEPTIDE β-AMYLOIDE |
EP0995756A2 (fr) * | 1998-07-31 | 2000-04-26 | Probiodrug Gesellschaft für Arzneimittelforschung mbH | Inhibiteurs orientés a méchanisme du peptidase dipeptidique I |
-
2001
- 2001-09-06 DE DE10143840A patent/DE10143840A1/de not_active Withdrawn
-
2002
- 2002-09-06 JP JP2003526944A patent/JP2005511505A/ja active Pending
- 2002-09-06 WO PCT/EP2002/010020 patent/WO2003022871A2/fr active Application Filing
- 2002-09-06 EP EP02779316A patent/EP1423410A2/fr not_active Withdrawn
- 2002-09-06 AU AU2002342657A patent/AU2002342657A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998022494A2 (fr) * | 1996-11-22 | 1998-05-28 | Elan Pharmaceuticals, Inc. | METHODES ET COMPOSES DESTINES A INHIBER LA LIBERATION ET/OU LA SYNTHESE DU PEPTIDE β-AMYLOIDE |
EP0995756A2 (fr) * | 1998-07-31 | 2000-04-26 | Probiodrug Gesellschaft für Arzneimittelforschung mbH | Inhibiteurs orientés a méchanisme du peptidase dipeptidique I |
Non-Patent Citations (6)
Title |
---|
BRÖMME D ET AL: "N,O-diacyl hydroxamates as selective and irreversible inhibitors of cysteine proteinases.", METHODS IN ENZYMOLOGY. UNITED STATES 1994, vol. 244, 1994, pages 671 - 685, XP009008478, ISSN: 0076-6879 * |
CHEN SHUI-TEIN ET AL: "One-pot synthesis of cathepsin inhibitors: N-alpha-protected N-peptidyl-O-acetylhydroxylamines catalysed by alcalase followed by lipase in anhydrous t-butanol.", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 2, no. 12, 1992, pages 1685 - 1690, XP009008477, ISSN: 0960-894X * |
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002236414, retrieved from STN Database accession no. 1998:352863 * |
DEMUTH H-U ET AL: "INHIBITION OF PROTEASES WITH ENKEPHALIN-ANALOGUE INHIBITORS", JOURNAL OF ENZYME INHIBITION, NEW YORK, NY, US, vol. 4, no. 4, 1991, pages 289 - 298, XP000876876 * |
DEMUTH H-U ET AL: "N-PEPTIDYL O-ACYL HYDROXAMATES: COMPARISON OF THE SELECTIVE INHIBITION OF SERINE AND CYSTEINE PROTEINASES", BBA - PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGIE, ELSEVIER SCIENCE BV, AMSTERDAM, NL, vol. 1295, no. 2, 18 July 1996 (1996-07-18), pages 179 - 186, XP000876878, ISSN: 0167-4838 * |
SMITH R A ET AL: "PEPTIDYL-O-ACYLHYDROXAMATES POTENT NEW INACTIVATORS OF CATHEPSIN B", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 155, no. 3, 1988, pages 1201 - 1206, XP009008480, ISSN: 0006-291X * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8883714B2 (en) | 2008-04-07 | 2014-11-11 | Arena Pharmaceuticals, Inc. | Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagogues |
Also Published As
Publication number | Publication date |
---|---|
WO2003022871A2 (fr) | 2003-03-20 |
JP2005511505A (ja) | 2005-04-28 |
AU2002342657A1 (en) | 2003-03-24 |
EP1423410A2 (fr) | 2004-06-02 |
DE10143840A1 (de) | 2003-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003022871A3 (fr) | Nouveaux inhibiteurs de dipeptidylpeptidase i | |
Hu et al. | Synthesis and Structure–activity Relationship of N-alkyl Gly-boro-Pro Inhibitors of DPP4, FAP, and DPP7 | |
SE9203825L (sv) | Dubbelt verkande inhibitorer foer no-syntas och cyklooxygenas, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma | |
SI1767535T1 (sl) | Sinteza epotilonov njihovih intermediatov analogov in uporaba le teh | |
EP2311851A3 (fr) | Inhibitoren der Serinproteasen, insbesondere der HCV-NS3-NS4A-Protease | |
PL332509A1 (en) | Beta-sulphonyl-hydroxamic acids as inhibitors of intercellular substance metaloproteinases | |
BRPI0212346B1 (pt) | Compostos derivados de benzotiadiazepina ou um sal farmaceuticamente aceitável do mesmo com efeito inibidor de transporte de ácido de bile ileal, processo para a preparação dos mesmos, uso destes, e, composição farmacêutica. | |
CA2367017A1 (fr) | Inhibiteurs de l'enzyme impdh | |
IL180722A0 (en) | Thienopyrimidine derivatives and pharmaceutical compositions containing the same | |
CA2461170A1 (fr) | Peptidyl-cetones comme inhibiteurs de molecules dipeptidyl peptidase de type iv | |
PE20070138A1 (es) | Compuestos heterociclicos como inhibidores de aspartil proteasas | |
MXPA05011150A (es) | 2-hidroxi-3-diaminoalcanos de benzamida. | |
MY138452A (en) | Novel process for synthesizing and a novel crystal form of agomelatine as well as pharmaceutical preparations containing these | |
IL143545A0 (en) | Thrombin inhibitors | |
TW200833682A (en) | Pharmaceutical compounds | |
AP1541A (en) | New thiadazoles and oxadiazoles and their use as phosphodiesterase - 7 inhibitors. | |
GEP20104882B (en) | Age inhibitors | |
CO5261493A1 (es) | Procedimiento y compuestos para la inhibicion de la mrp1 | |
TR200400003T4 (tr) | (S)-2-Ethoxy -3-4-(2-4-Methanesulfonyloxyphenyl ethoxy) propanoic asidin birleştirilmiş hali | |
HUP9900390A2 (hu) | Szerin-proteáz-inhibitorok és ezeket tartalmazó gyógyszerkészítmények | |
CY1107367T1 (el) | Σαρωση για πεπτιδια που αναστελουν προσδεση της pp1c στις πρωτεϊνες bcl-2, bcl-xl και bcl-w | |
DE602004029355D1 (de) | Sulfopyrrolderivate | |
WO2003022844A3 (fr) | Synthese d'epothilones, intermediaires destines a ces dernieres et analogues d'epothilones | |
Reiter et al. | Difluoroketones as inhibitors of matrix metalloprotease-13 | |
WO2003015706A3 (fr) | Composes d'acide borinique utiles en tant qu'inhibiteurs de proteases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002779316 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003526944 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002779316 Country of ref document: EP |